• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Value-Based Cardiovascular Care: Developing Cost Measures for Percutaneous Coronary Intervention.

作者信息

Joynt Maddox Karen E, Johnston Kenton J

机构信息

Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO (K.E.J.M.).

Center for Health Economics and Policy, Institute for Public Health at Washington University, St. Louis, MO (K.E.J.M.).

出版信息

Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e007753. doi: 10.1161/CIRCOUTCOMES.121.007753. Epub 2021 Mar 3.

DOI:10.1161/CIRCOUTCOMES.121.007753
PMID:33653115
Abstract
摘要

相似文献

1
Value-Based Cardiovascular Care: Developing Cost Measures for Percutaneous Coronary Intervention.基于价值的心血管护理：制定经皮冠状动脉介入治疗的成本衡量标准。
Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e007753. doi: 10.1161/CIRCOUTCOMES.121.007753. Epub 2021 Mar 3.
2
Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.经皮冠状动脉介入治疗的 Medicare 受益患者中与入路部位相关的成本和当日出院：对美国当前经皮冠状动脉介入治疗护理路径的评估。
JACC Cardiovasc Interv. 2017 Feb 27;10(4):342-351. doi: 10.1016/j.jcin.2016.11.049.
3
Novel Patient-Centered Approach to Facilitate Same-Day Discharge in Patients Undergoing Elective Percutaneous Coronary Intervention.新型以患者为中心的方法促进择期经皮冠状动脉介入治疗患者当日出院。
J Am Heart Assoc. 2018 Feb 15;7(4):e005733. doi: 10.1161/JAHA.117.005733.
4
Antiplatelet therapy in patients with glucose-6-phosphate dehydrogenases deficiency after percutaneous coronary intervention: A reappraisal for clinical and interventional cardiologists.葡萄糖-6-磷酸脱氢酶缺乏症患者经皮冠状动脉介入治疗后的抗血小板治疗：临床和介入心脏病学家的重新评估
Cardiovasc Revasc Med. 2017 Apr-May;18(3):226-229. doi: 10.1016/j.carrev.2016.11.011. Epub 2016 Nov 28.
5
The cost-effectiveness of strategies in coronary artery disease.冠状动脉疾病治疗策略的成本效益
Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):805-13. doi: 10.1586/14737167.2014.957681. Epub 2014 Oct 1.
6
Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.从荷兰视角看经皮冠状动脉介入治疗与搭桥手术的成本效益
Heart. 2015 Dec;101(24):1980-8. doi: 10.1136/heartjnl-2015-307578. Epub 2015 Nov 9.
7
COURAGE or FAME...? Who should have percutaneous coronary intervention in stable coronary artery disease?勇气还是声誉……？谁应该接受经皮冠状动脉介入治疗来治疗稳定型冠状动脉疾病？
Heart. 2013 Apr;99(7):442-4. doi: 10.1136/heartjnl-2012-303029. Epub 2012 Oct 19.
8
Annual cost of stable coronary artery disease in France: A modeling study.法国稳定型冠状动脉疾病的年度成本：一项建模研究。
Arch Cardiovasc Dis. 2015 Nov;108(11):576-88. doi: 10.1016/j.acvd.2015.06.006. Epub 2015 Oct 1.
9
In-Stent Dissection Causes No Flow During Percutaneous Coronary Intervention.经皮冠状动脉介入治疗期间，支架内夹层导致无血流。
JACC Cardiovasc Interv. 2016 Jan 11;9(1):102-103. doi: 10.1016/j.jcin.2015.09.025. Epub 2015 Dec 9.
10
Meta-analysis of long-term outcomes of percutaneous coronary intervention versus medical therapy in stable coronary artery disease.稳定型冠状动脉疾病经皮冠状动脉介入治疗与药物治疗长期疗效的荟萃分析。
Eur J Prev Cardiol. 2019 Mar;26(4):433-436. doi: 10.1177/2047487318800511. Epub 2018 Sep 18.